V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320002686 | 320001590 | 1.6 | 62 | Palliative (P) | null | 2017-03-09 | GemCarbo Days 1+8 | 02 | N | 320016058 | GEMCARBO |
| 320002687 | 320001591 | 1.61 | 55 | Neo-adjuvant (N) | 2017-02-28 | 2017-03-10 | CISPLATIN + FLUOROURACIL | N | null | 320016069 | CISPLATIN + FLUOROURACIL |
| 320002688 | 320001592 | 1.65 | 74.6 | null | 2016-05-04 | 2016-06-02 | CISPLATIN + FLUOROURACIL | N | null | 320016072 | CISPLATIN + FLUOROURACIL |
| 320002689 | 320001593 | 1.78 | 50 | Curative (C) | 2017-01-11 | 2017-02-17 | Cisplatin | N | N | 320016075 | CISPLATIN |
| 320002690 | 320001594 | 1.64 | null | Palliative (P) | 2014-12-17 | 2014-12-19 | NB HRNBL-1 COJEC Ind COURSE A | N | N | 320016077 | CISPLATIN + ETOPOSIDE |
| 320002691 | 320001595 | null | null | Neo-adjuvant (N) | 2016-05-03 | 2016-05-10 | Capecitabine (14 days)+Carboplatin | N | N | 320016079 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 320002692 | 320001596 | null | 69.5 | Neo-adjuvant (N) | 2016-04-16 | 2016-04-29 | FLUOROURACIL + OXALIPLATIN | null | null | 320016089 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320002693 | 320001597 | 1.87 | 79.6 | null | null | 2015-12-04 | CISPLATIN + ETOPOSIDE | null | null | 320016091 | CAPECITABINE + CISPLATIN |
| 320002694 | 320001598 | 1.73 | 82 | Curative (C) | 2015-05-08 | 2015-05-22 | Cetuximab + CISPLATIN + FLUOROURACIL | null | null | 320016094 | TIP |
| 320002695 | 320001599 | 1.48 | 105.9 | Not known (9) | null | 2015-03-05 | CISPLATIN + ETOPOSIDE | null | null | 320016099 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320002696 | 320001600 | 1.6 | 61.8 | Curative (C) | 2013-12-11 | 2014-01-09 | FLUOROURACIL + OXALIPLATIN | N | N | 320016100 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320002697 | 320001600 | 1.89 | 72.6 | Curative (C) | 2015-09-19 | 2015-10-18 | BCG Intravesical | 2 | N | 320016100 | OXALIPLATIN + MDG |
| 320002698 | 320001601 | null | 97.6 | Palliative (P) | 2014-11-17 | 2014-11-24 | Cisplatin + Gemcitabine (D 1 & 8) | Y | N | 320016106 | FLUOROURACIL |
| 320002699 | 320001602 | 1.8 | 0 | null | 2017-12-18 | 2017-12-29 | Fluorouricil + Folonic Acid (MdG) | N | N | 320016114 | CETUXIMAB + CISPLATIN + FU |
| 320002700 | 320001603 | 1.66 | null | Palliative (P) | 2014-05-13 | 2014-05-19 | Cisplatin + Etoposide (3 day) | null | null | 320016116 | CISPLATIN + PEMETREXED |
| 320002701 | 320001603 | 1.2 | 95 | Curative (C) | 2015-11-17 | 2015-12-10 | ECX | N | Y | 320016116 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320002702 | 320001604 | 1.61 | 53.85 | Palliative (P) | null | 2016-09-09 | Trial Unspecified | 02 | N | 320016120 | CARBO + FLUOROURACIL |
| 320002703 | 320001605 | null | null | Palliative (P) | 2015-10-21 | 2015-11-04 | Bevacizumab+Carbo+Pacliaxel | N | null | 320016123 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320002704 | 320001605 | 1.71 | 0 | Adjuvant (A) | 2014-01-18 | 2014-01-18 | BCG Intravesical | 2 | null | 320016123 | IMATINIB |
| 320002705 | 320001605 | 1.78 | null | Neo-adjuvant (N) | 2014-10-25 | 2014-11-09 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 320016123 | BEVACIZUMAB |
| 320002706 | 320001605 | 1.67 | 69 | Palliative (P) | 2016-08-02 | 2016-08-11 | CAPECITABINE + OXALIPLATIN | N | N | 320016123 | CAPECITABINE + CARBOPLATIN |
| 320002707 | 320001606 | 1.89 | 132 | Curative (C) | 2014-10-15 | 2014-11-10 | Cisplatin + Pemetrexed | 2 | Y | 320016159 | EOX |
| 320002708 | 320001606 | null | 83 | Curative (C) | 2018-06-16 | 2018-06-17 | EOX | N | null | 320016159 | CETUXIMAB |
| 320002709 | 320001606 | 1.75 | 42 | Palliative (P) | 2017-05-08 | 2017-05-08 | CETUXIMAB + RT | 02 | null | 320016159 | CISPLATIN + GEMCITABINE |
| 320002710 | 320001607 | 1.55 | 79.9 | Neo-adjuvant (N) | 2016-02-08 | 2016-02-08 | Trial Unspecified | 02 | N | 320016175 | CARBOPLATIN + VINCRISTINE |
| 320002711 | 320001608 | 1.55 | 81 | null | 2015-11-19 | 2015-11-26 | PCV | N | N | 320016180 | CARBOPLATIN + DOXORUBICIN |
| 320002712 | 320001608 | 1.62 | 24.6 | Palliative (P) | null | 2014-03-16 | Bevacizumab 7.5mg/kg | N | N | 320016180 | CARBOPLATIN + RT |
| 320002713 | 320001608 | 1.73 | 84 | Palliative (P) | 2013-07-13 | 2013-07-26 | Capecitabine+Cisplatin+Streptozocin | 1 | null | 320016180 | PMB |
| 320002714 | 320001609 | 1.71 | 92.5 | Adjuvant (A) | 2017-03-23 | 2017-04-02 | IVA | N | N | 320016198 | TIP |
| 320002715 | 320001610 | 1.69 | 80 | Neo-adjuvant (N) | 2016-03-27 | 2016-03-30 | Vinflunine | N | N | 320016200 | CARBOPLATIN + RT |
| 320002716 | 320004864 | 1.76 | 75 | Palliative (P) | 2016-06-21 | 2016-06-28 | Cisplatin + Gemcitabine (D 1 & 8) | null | N | 320016208 | PAZOPANIB |
| 320002717 | 320004864 | 1.83 | null | Adjuvant (A) | 2015-04-09 | 2015-04-09 | Cetuximab + Radiotherapy Load | N | null | 320016208 | CETUXIMAB + RT |
| 320002719 | 320001611 | 1.52 | 55.8 | Adjuvant (A) | 2014-09-22 | 2015-06-21 | ICON8 TRIAL | 02 | N | 320016229 | BEVACIZUMAB |
| 320002720 | 320004865 | 1.7 | 74 | Palliative (P) | 2016-05-04 | 2016-05-17 | ECX | 02 | N | 320016235 | MMM |
| 320002721 | 320001612 | 1.68 | null | Neo-adjuvant (N) | 2014-11-14 | 2014-11-24 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 320016238 | CETUXIMAB + RT |
| 320002722 | 320001613 | 1.78 | 73 | Disease modification (D) | 2017-06-28 | 2017-07-14 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 320016246 | IPILIMUMAB + NIVOLUMAB |
| 320002724 | 320004866 | 1.66 | 88.6 | Curative (C) | 2017-04-05 | 2017-04-06 | BCG Intravesical | Y | N | 320016253 | CISPLATIN + GEMCITABINE |
| 320002725 | 320001615 | 1.57 | null | Curative (C) | 2014-01-28 | 2014-03-11 | Bevacizumab+Carbo+Gemcitabine | N | Y | 320016254 | CARBO + FLUOROURACIL |
| 320002726 | 320001616 | 1.66 | 79.8 | null | 2014-06-21 | 2014-06-21 | Folfirinox | 01 | null | 320016272 | OXALIPLATIN + MDG |
| 320002727 | 320001617 | 1.6 | 63.3 | Palliative (P) | 2016-02-16 | 2016-03-25 | Ipilimumab | N | N | 320016275 | CAPECITABINE + GEMCITABINE |
| 320002728 | 320001618 | 1.63 | 50.3 | Palliative (P) | 2017-07-22 | 2017-08-19 | Cisplatin + Gemcitabine (D 1 & 8) | N | Y | 320016279 | ICON8B TRIAL |
| 320002729 | 320001619 | 1.63 | 70 | Curative (C) | 2013-08-17 | 2013-09-14 | Bevacizumab+Carbo+Pacliaxel | N | N | 320016282 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320002730 | 320001620 | 1.65 | null | Adjuvant (A) | null | 2017-04-01 | CISPLATIN + ETOPOSIDE | N | N | 320016287 | CISPLATIN + GEMCITABINE |
| 320002731 | 320004867 | 0 | 74.5 | Palliative (P) | 2016-12-11 | 2016-12-18 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 320016288 | GEMCITABINE + RT |
| 320002732 | 320006278 | 1.53 | 46 | Neo-adjuvant (N) | null | 2014-05-30 | Cisplatin + Etoposide po&iv 3 day | null | null | 320016292 | CARBO + FLUOROURACIL |
| 320002733 | 320006278 | 1.94 | 116.4 | Palliative (P) | 2016-02-04 | 2016-02-07 | Cetuximab + Radiotherapy Maint | 2 | N | 320016292 | CAPECITABINE + OXALIPLATIN |
| 320002734 | 320007216 | 1.67 | 78.1 | Palliative (P) | null | 2016-01-26 | Cisplatin + Docetaxel +Fluorouracil | null | null | 320016306 | TIP |
| 320002735 | 320007216 | 0 | 66.7 | null | 2016-04-09 | 2016-04-13 | ICON8B TRIAL | 2 | N | 320016306 | CHOP R |
| 320002736 | 320007216 | 1.6 | 59.2 | Curative (C) | 2014-05-24 | 2014-06-06 | Bevacizumab 7.5mg/kg | Y | N | 320016306 | EC + DOCETAXEL |
| 320002737 | 320001621 | 1.8 | null | Curative (C) | 2016-05-02 | 2016-05-08 | Capecitabine + Cisplatin | 02 | N | 320016311 | ECX |